Satellos Bioscience Inc.

MSCLF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$6-$6-$6-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$0
Change in WC$1$0-$2-$1
Other Non-Cash$0-$0-$0-$1
Operating Cash Flow-$4-$5-$7-$8
Investing Activities
PP&E Inv.-$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$15$0$0$0
Inv. Sales/Matur.$0$8$0$26
Other Inv. Act.-$0$0$0-$37
Investing Cash Flow-$15$8$0-$12
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$1$0$43
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$0$10
Financing Cash Flow$1$1$0$53
Forex Effect-$0$0$0$0
Net Chg. in Cash-$19$6-$7$34
Supplemental Information
Beg. Cash$38$33$40$23
End Cash$19$38$33$58
Free Cash Flow-$4-$5-$7-$8
Satellos Bioscience Inc. (MSCLF) Financial Statements & Key Stats | AlphaPilot